Idiopathic Thrombocytopenic Purpura : A Review and Case Report
Divya
Amaravadi1*, Bukka Dheeraj
Kumar2, Anche Janani2
1.Assistant
Professor, Department of Pharmacy Practice, School of
Pharmacy, Anurag
University, Hyderabad, Telangana, India.
2.Pharm.D IV Year, Department of Pharmacy Practice, School of Pharmacy, Anurag University, Hyderabad, Telangana, India.
ABSTRACT
Immune thrombocytopenia (ITP) is a diverse condition in which managing and predicting
patient responses to therapy poses a problem. It can develop in healthy
people, including kids and young adults, after a viral infection and significantly impair a patient's quality of life. Thrombopoietin receptor agonists (TPO-RAs), spleen tyrosine kinase (Syk) inhibitors, or immunological suppression (corticosteroids and intravenous
immunoglobulins) are the mainstays of ITP treatment. This article provides a
quick overview of the occurrence, aetiology, classification, and several
therapy approaches
based on recent research. We also present a case report on ITP and summarize the key points in the
diagnosis and management of it. In order to improve the disease prognosis and lower the incidence or
frequency of refractoriness,
a deeper understanding of ITP is needed in order to offer patients with individualized therapy alternatives.
Keywords: Immune
thrombocytopenia, Thrombopoietin receptor agonists, corticosteroids, Syk inhibitors, immunoglobulins.